CATALOGO DEI PRODOTTI DELLA RICERCA

ADAMI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.366
NA - Nord America 3.694
AS - Asia 3.237
SA - Sud America 511
AF - Africa 104
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.922
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.606
RU - Federazione Russa 2.127
SG - Singapore 1.282
CN - Cina 992
GB - Regno Unito 556
BR - Brasile 433
IT - Italia 387
HK - Hong Kong 341
DE - Germania 329
SE - Svezia 238
FR - Francia 228
IE - Irlanda 219
VN - Vietnam 156
IN - India 144
KR - Corea 105
FI - Finlandia 97
JP - Giappone 62
CA - Canada 44
MX - Messico 34
NL - Olanda 31
BJ - Benin 30
AR - Argentina 28
ID - Indonesia 27
PL - Polonia 27
TG - Togo 27
TR - Turchia 27
AT - Austria 25
BD - Bangladesh 25
ZA - Sudafrica 25
ES - Italia 22
UA - Ucraina 20
IQ - Iraq 15
CO - Colombia 10
EC - Ecuador 10
VE - Venezuela 9
BE - Belgio 8
UZ - Uzbekistan 8
IR - Iran 7
PT - Portogallo 7
CH - Svizzera 6
EG - Egitto 6
GR - Grecia 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
CL - Cile 5
PK - Pakistan 5
PY - Paraguay 5
CZ - Repubblica Ceca 4
IL - Israele 4
LT - Lituania 4
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
ET - Etiopia 3
JO - Giordania 3
KG - Kirghizistan 3
KW - Kuwait 3
LV - Lettonia 3
MA - Marocco 3
NZ - Nuova Zelanda 3
PE - Perù 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AM - Armenia 2
BY - Bielorussia 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GE - Georgia 2
HR - Croazia 2
ME - Montenegro 2
MK - Macedonia 2
MY - Malesia 2
PA - Panama 2
PH - Filippine 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
TN - Tunisia 2
TW - Taiwan 2
A1 - Anonimo 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
CD - Congo 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
GF - Guiana Francese 1
GN - Guinea 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MN - Mongolia 1
Totale 11.917
Salva come PNG Salva come JPEG
Città #
Moscow 790
Dallas 638
Chandler 488
Singapore 477
Southend 448
Ashburn 368
Hong Kong 335
Dublin 214
Beijing 171
New York 111
Los Angeles 109
Jacksonville 101
Redmond 90
Wilmington 78
Lawrence 74
Princeton 74
Bologna 68
Verona 65
Ann Arbor 61
Tokyo 61
Jinan 60
Ho Chi Minh City 59
Munich 59
Helsinki 55
Shenyang 54
The Dalles 54
Buffalo 53
Redondo Beach 48
Hyderabad 47
Nanjing 46
Sindelfingen 46
São Paulo 42
London 39
Seattle 37
Tianjin 36
Woodbridge 35
Falkenstein 34
Hebei 34
Columbus 32
Santa Clara 32
Cotonou 30
Hanoi 27
Lomé 27
Washington 27
Zhengzhou 27
Warsaw 25
Brooklyn 24
Denver 24
Guangzhou 23
Hangzhou 23
Houston 23
Milan 23
Turku 23
Changsha 22
Taiyuan 22
Haikou 21
San Francisco 20
Nanchang 19
Ningbo 19
Rome 19
Stockholm 17
Dongguan 16
Orem 16
Poplar 16
Chicago 15
Fairfield 15
Jakarta 15
Jiaxing 15
Johannesburg 15
Montreal 15
Redwood City 15
Boston 14
Mexico City 14
Taizhou 14
Chennai 13
Rio de Janeiro 13
Atlanta 12
Council Bluffs 12
Manchester 11
Norwalk 11
Seoul 11
Venice 11
Brasília 10
Vienna 10
Amsterdam 9
Miami 9
Phoenix 9
Belo Horizonte 8
Biên Hòa 8
Campinas 8
Da Nang 8
Falls Church 8
Fuzhou 8
Naples 8
Tashkent 8
Ankara 7
Brussels 7
Dearborn 7
Querétaro 7
Secaucus 7
Totale 6.643
Salva come PNG Salva come JPEG
Nome #
A case of adult chronic recurrent multifocal osteomyelitis successfully treated with neridronate 218
Anti-CCP antibodies and bone 197
Hajdu Cheney Syndrome; report of a novel NOTCH2 mutation and treatment with denosumab 182
Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women 182
Amino-Bisphosphonates and Cardiovascular Risk: A New Hypothesis Involving the Effects on Gamma-Delta T Cells 174
Comment on: clinical efficacy of oral alendronate in ankylosing spondylitis: a randomised placebo-controlled trial 168
Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone 163
Could γ\δ T-cells explain zoledronic acid adverse events? 162
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 162
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 158
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 154
Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis 152
An exploratory study on the role of vitamin D supplementation in improving pain and disease activity in rheumatoid arthritis 150
Parathyroid hormone is a determinant of serum Dickkopf-1 levels in ankylosing spondylitis 148
Correction to: Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 147
Association Between Short-term Exposure to Environmental Air Pollution and Psoriasis Flare 143
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 140
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 137
Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis 135
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations 134
Safety issues and adverse reactions with osteoporosis management 133
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis? 132
Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Disease activity, rather than glucocorticoid therapy, may be associated with COVID-19 severity in patients with rheumatic musculoskeletal diseases 131
Association between environmental air pollution and rheumatoid arthritis flares 129
Denosumab, cortical bone and bone erosions in rheumatoid arthritis 127
Factors associated with referral for osteoporosis care in men: a real-life study of a nationwide dataset 127
Osteoporosis: an Independent Determinant of Bone Erosions in Rheumatoid Arthritis? 126
Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker 126
Association between acute exposure to environmental air pollution and fragility hip fractures 124
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 122
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 122
Short-Term Effects of TNF Inhibitors on Bone Turnover Markers and Bone Mineral Density in Rheumatoid Arthritis 121
Calcium and vitamin D supplementation: when and why 121
Inhibition of tumor necrosis factor-alpha (TNF-alpha) in patients with early rheumatoid arthritis results in acute changes of bone modulators 118
Rheumatoid arthritis, γδ T cells and bisphosphonates 117
A Prospective Open‐Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The GastroPASS Study 117
The obesity paradox and osteoporosis 116
Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID) 116
Is central sensitization an important determinant of functional disability in patients with chronic inflammatory arthritides? 115
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 115
Acute Phase Reaction and Fracture Risk Reduction. Are Gamma‐Delta T Cells and hypovitaminosis D the Missing Link? 115
Long-term effectiveness and predictors of bisphosphonate treatment in type I complex regional pain syndrome 113
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 113
Osteoporosis in Rheumatic Diseases 113
Osteoporosis in Inflammatory Arthritides: New Perspective on Pathogenesis and Treatment 112
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 109
Correction to: The obesity paradox and osteoporosis 107
Higher body mass index is associated with a lower iloprost infusion rate tolerance and higher iloprost-related adverse events in patients with systemic sclerosis 105
Gender disparity in authorship of guidelines and recommendations in rheumatology 105
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 104
A Prospective Open-Label Observational Study of a Buffered Soluble 70{\hspace{0.167em}}mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medication Errors: The {GastroPASS} Study 104
Pharmacokinetics of Oral Cholecalciferol in Healthy Subjects with Vitamin D Deficiency: A Randomized Open-Label Study 103
Association between short-term exposure to environmental air pollution and atopic dermatitis flare in patients treated with dupilumab 101
Wnt Inhibitors and Bone Turnover Markers in Patients With Polymyalgia Rheumatica and Acute Effects of Glucocorticoid Treatment 101
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 101
The Emerging Roles of Endocrine Hormones in Different Arthritic Disorders 100
Predictors and prognostic role of low myocardial mechano-energetic efficiency in chronic inflammatory arthritis 99
Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis 99
Bone Loss in Inflammatory Rheumatic Musculoskeletal Disease Patients Treated With Low-Dose Glucocorticoids and Prevention by Anti-Osteoporosis Medications 97
Efficacy of mud plus bath therapy as compared to bath therapy in osteoarthritis of hands and knees: a pilot single-blinded randomized controlled trial 97
Changes in bone turnover markers and bone modulators during abatacept treatment 95
Pharmacological treatment in adult patients with CRPS-I: A systematic review and meta-analysis of randomised controlled trials 95
Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency 92
Eosinophilic Granulomatosis With Polyangiitis and Cardiac Involvement: A Case Report 92
Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort 91
Vitamin D and disease severity in coronavirus disease 19 (COVID-19) 90
Tumour necrosis factor inhibitors reduce aortic stiffness progression in patients with long-standing rheumatoid arthritis 90
Left ventricular hypertrophy predicts poorer cardiovascular outcome in normotensive normoglycemic patients with rheumatoid arthritis 89
Tapering glucocorticoids and risk of flare in rheumatoid arthritis on biological disease-modifying antirheumatic drugs (bDMARDs) 88
Barnidipine as a potential alternative treatment for Raynaud's phenomenon secondary to systemic sclerosis: a retrospective pilot study 88
Could Previous Exposure to Nitrogen-Containing Bisphosphonates Mitigate Friendly Fire? 87
The Use of Oral Amino-Bisphosphonates and Coronavirus Disease 2019 (COVID-19) Outcomes 83
The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases 82
Bone health status evaluation in men by means of REMS technology 81
Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3 80
Balancing benefits and risks in the era of biologics 79
Lack of Effect of Teriparatide on Joint Erosions in Rheumatoid Arthritis Is an Expected Result: Comment on the Article by Solomon et al 78
Effectiveness of influenza vaccine in TNF inhibitors treated patients: comment on the article by Burmester et al 78
Glucocorticoid-induced osteoporosis: 2019 concise clinical review 77
Response to: ‘Correspondence on ‘Gender disparity in authorship of guidelines and recommendations in rheumatology’’ by Stewart et al 76
Comments on Kanis et al.: Algorithm for the management of patients at low, high, and very high risk of osteoporotic fractures 75
Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs) 74
Secukinumab produces a quick increase in WNT signalling antagonists in patients with psoriatic arthritis 73
Osteoporosis in 10 years time: a glimpse into the future of osteoporosis 73
Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: An analysis on a nation-wide database 71
Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study 68
Glucocorticoid sparing effect of Janus Kinase inhibitors compared to biological Disease Modifying Anti-Rheumatic Drugs in rheumatoid arthritis, a single-center retrospective analysis 68
The role of 18FDG-PET imaging in VEXAS syndrome: a multicentric case series and a systematic review of the literature 67
Effect of neridronate in osteopenic patients after heart, liver or lung transplant: a multicenter, randomized, double-blind, placebo-controlled study 65
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal 65
Machine learning to characterize bone biomarkers profile in rheumatoid arthritis 62
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis 62
New insights on the role, pathogenesis, and treatment of osteoporosis and bone erosions in rheumatoid arthritis 62
Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life 62
Temporal Trends and Factors Associated with Bisphosphonate Discontinuation and Restart 61
Cardiovascular Safety of Romosozumab: New Insights from Postmenopausal Women with Chronic Kidney Disease 60
Osteoporosis and fractures in systemic vasculitides: a systematic review and meta-analysis 59
Radiofrequency echographic multi spectrometry for the prediction of incident fragility fractures: A 5-year follow-up study 59
Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes 59
Systematic study on nail plate assessment: differences in nail plate shape, thickness, power Doppler signal and scanning approach 58
Totale 10.773
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.517
article - articoli 47.299
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 192
patent - brevetti 0
selected - selezionate 0
volume - volumi 26
Totale 95.034
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021292 0 0 0 0 58 44 40 5 52 5 55 33
2021/2022579 59 129 8 20 30 21 15 34 56 20 27 160
2022/20231.499 88 151 118 286 127 345 15 68 170 36 74 21
2023/2024982 40 70 89 125 80 202 54 44 30 43 151 54
2024/20252.632 111 132 104 409 160 79 136 103 402 318 231 447
2025/20264.788 538 391 612 1.453 1.794 0 0 0 0 0 0 0
Totale 12.175